Drugs / Meningococcal ACWY-CRM conjugate vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01973218 Comparator | Nov 2013 → Apr 2014 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal ACWY-CRM conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01973218 ↗ |
| Known as | MenACWY-CRM | “a quadrivalent meningococcal ACWY glycoconjugate vaccine (MenACWY-CRM)” PMID 26826544 ↗ Jan 2016 |
| Modality | Vaccine | “a quadrivalent meningococcal ACWY glycoconjugate vaccine (MenACWY-CRM)” PMID 26826544 ↗ Jan 2016 |
| Route | Intramuscular | “receive intramuscular (IM) injection of saline solution followed by one dose of MenACWY-CRM vaccine (0.5 mL), one month apart” NCT01973218 ↗ |